We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$311B
AUM Growth
+$27B
Cap. Flow
-$2.73B
Cap. Flow %
-0.88%
Top 10 Hldgs %
26.14%
Holding
3,413
New
219
Increased
1,869
Reduced
1,057
Closed
98

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$482M
2
SHOP icon
Shopify
SHOP
+$353M
3
INTC icon
Intel
INTC
+$318M
4
NKE icon
Nike
NKE
+$312M
5
UBS icon
UBS Group
UBS
+$309M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$520M
2
ORCL icon
Oracle
ORCL
+$471M
3
CRM icon
Salesforce
CRM
+$452M
4
EOG icon
EOG Resources
EOG
+$360M
5
META icon
Meta Platforms (Facebook)
META
+$246M

Sector Composition

Rank Sector Weight
1 Technology 28.65%
2 Financials 12.19%
3 Healthcare 11.7%
4 Consumer Discretionary 11.15%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHTH icon
2701
eHealth
EHTH
$43.9M
$1M ﹤0.01%
115,039
+1,782
+2% +$14.6K
XERS icon
2702
Xeris Biopharma Holdings
XERS
$1.45B
$999K ﹤0.01%
424,972
-287,725
-40% -$531K
CLFD icon
2703
Clearfield
CLFD
$374M
$994K ﹤0.01%
34,183
+251
+0.7% +$6.69K
CARE icon
2704
Carter Bankshares
CARE
$731M
$991K ﹤0.01%
66,206
+541
+0.8% +$6.81K
LGTY
2705
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$990K ﹤0.01%
87,587
+912
+1% +$9.8K
REPL icon
2706
Replimune Group
REPL
$1.01B
$986K ﹤0.01%
116,987
+12,756
+12% +$148K
RCEL icon
2707
Avita Medical
RCEL
$240M
$984K ﹤0.01%
71,738
CART icon
2708
Maplebear
CART
$11.8B
$982K ﹤0.01%
+41,860
New +$1.05M
CCBG icon
2709
Capital City Bank Group
CCBG
$890M
$981K ﹤0.01%
33,336
+153
+0.5% +$4.44K
WOOF icon
2710
Petco
WOOF
$794M
$980K ﹤0.01%
310,135
-3,986
-1% -$13.8K
PAGP icon
2711
Plains GP Holdings
PAGP
$4.9B
$979K ﹤0.01%
61,365
-23,677
-28% -$374K
CMT icon
2712
Core Molding Technologies
CMT
$234M
$976K ﹤0.01%
52,668
-8,170
-13% -$178K
GLRE icon
2713
Greenlight Captial
GLRE
$506M
$967K ﹤0.01%
84,671
+846
+1% +$9.41K
ALNT icon
2714
Allient
ALNT
$1.92B
$963K ﹤0.01%
31,878
+210
+0.7% +$5.92K
CERS icon
2715
Cerus
CERS
$474M
$960K ﹤0.01%
444,639
-1,011,105
-69% -$1.67M
PRME icon
2716
Prime Medicine
PRME
$559M
$958K ﹤0.01%
108,093
+1,171
+1% +$9.02K
ARTNA icon
2717
Artesian Resources
ARTNA
$358M
$956K ﹤0.01%
23,052
+2,206
+11% +$92.2K
IAG icon
2718
IAMGOLD
IAG
$10.5B
$955K ﹤0.01%
+377,190
New +$904K
UTMD icon
2719
Utah Medical Products
UTMD
$225M
$954K ﹤0.01%
11,329
+2,490
+28% +$207K
HIFS icon
2720
Hingham Institution for Saving
HIFS
$663M
$954K ﹤0.01%
4,906
+800
+19% +$137K
AGEN
2721
Agenus
AGEN
$290M
$951K ﹤0.01%
57,412
+921
+2% +$15.3K
PSTX
2722
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$950K ﹤0.01%
282,631
-82,560
-23% -$213K
WSBF icon
2723
Waterstone Financial
WSBF
$375M
$941K ﹤0.01%
66,292
+659
+1% +$7.79K
MGTX icon
2724
MeiraGTx Holdings
MGTX
$1.21B
$938K ﹤0.01%
133,574
+741
+0.6% +$3.66K
OFLX icon
2725
Omega Flex
OFLX
$312M
$935K ﹤0.01%
13,265
-3,030
-19% -$226K

Similar funds

Nuveen's Q4 2023 Portfolio in Review

As of Q4 2023, Nuveen held 3,413 positions worth $311B, up 9.5% from $284B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q4 2023 filing shows 219 new, 1,869 increased, 1,057 reduced and 98 closed positions. Its largest new stake was CRH: 7,989,897 shares worth $552M. The largest sale was Amazon, an estimated $520M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2023 buy was CRH: 7,989,897 shares worth $552M.
  • Nuveen added most to Intel in Q4 2023, an estimated $318M increase.
  • Nuveen's biggest Q4 2023 reduction was Amazon, cutting an estimated $520M.
  • Nuveen fully exited Activision Blizzard in Q4 2023, selling an estimated $194M.
  • Nuveen's ten largest holdings make up 26% of its $311B portfolio in Q4 2023.
  • Nuveen opened 219 new positions and closed 98 in Q4 2023.
  • Nuveen's portfolio value rose 9.5% quarter-over-quarter to $311B.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.